Literature DB >> 2863502

Prospective study of acquisition of Cryptosporidium, Giardia lamblia, and gastrointestinal illness.

A M Jokipii, M Hemilä, L Jokipii.   

Abstract

Entities:  

Mesh:

Year:  1985        PMID: 2863502     DOI: 10.1016/s0140-6736(85)90412-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Epidemiological aspects of human cryptosporidiosis.

Authors:  D P Casemore
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

2.  Cryptosporidium and diarrhoea.

Authors:  J G Bissenden
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-02

Review 3.  Immune response to Giardia duodenalis.

Authors:  G Faubert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 4.  Cryptosporidium species, a protean protozoan.

Authors:  E N Janoff; L B Reller
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

5.  Folate deficiency due to giardiasis.

Authors:  N S Ambrose; S Hutchison; J Tejan
Journal:  J R Soc Med       Date:  1989-01       Impact factor: 5.344

6.  Two year study of cryptosporidium infection.

Authors:  M A Thomson; J W Benson; P A Wright
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

Review 7.  Cryptosporidium spp. and cryptosporidiosis.

Authors:  R Fayer; B L Ungar
Journal:  Microbiol Rev       Date:  1986-12

8.  Antibodies to cysts of Giardia lamblia in primary giardiasis and in the absence of giardiasis.

Authors:  L Jokipii; A Miettinen; A M Jokipii
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

Review 9.  Drugs for treating giardiasis.

Authors:  Carlos E Granados; Ludovic Reveiz; Luis G Uribe; Claudia P Criollo
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

10.  Quantification of specific antibody response to Cryptosporidium antigens by laser densitometry.

Authors:  B L Ungar; T E Nash
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.